Sun Pharma to buy US-listed Organon in about $11.8 billion deal
NewDelhi: Sun Pharmaceutical Industries will acquire Organon & Co in an all‑cash deal, valuing the U.S. drugmaker at about $11.75 billion including debt, in one […]
#SunPharma #BSE #NSE #US